chr22-46335637-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000441818.5(TRMU):c.-128A>G variant causes a 5 prime UTR, NMD transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0173 in 1,100,446 control chromosomes in the GnomAD database, including 335 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 38 hom., cov: 32)
Exomes 𝑓: 0.017 ( 297 hom. )
Consequence
TRMU
ENST00000441818.5 5_prime_UTR, NMD_transcript
ENST00000441818.5 5_prime_UTR, NMD_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.269
Genes affected
TRMU (HGNC:25481): (tRNA mitochondrial 2-thiouridylase) This nuclear gene encodes a mitochondrial tRNA-modifying enzyme. The encoded protein catalyzes the 2-thiolation of uridine on the wobble positions of tRNA(Lys), tRNA(Glu), and tRNA(Gln), resulting in the formation of 5-taurinomethyl-2-thiouridine moieties. Mutations in this gene may cause transient infantile liver failure. Polymorphisms in this gene may also influence the severity of deafness caused by mitochondrial 12S ribosomal RNA mutations. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 22-46335637-A-G is Benign according to our data. Variant chr22-46335637-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 341998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-46335637-A-G is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0753 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRMU | ENST00000441818.5 | c.-128A>G | 5_prime_UTR_variant, NMD_transcript_variant | 1/10 | 1 | ||||
TRMU | ENST00000456595.5 | c.-128A>G | 5_prime_UTR_variant, NMD_transcript_variant | 1/9 | 1 | ||||
TRMU | ENST00000381021.7 | c.-128A>G | 5_prime_UTR_variant, NMD_transcript_variant | 1/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0162 AC: 2464AN: 151848Hom.: 38 Cov.: 32
GnomAD3 genomes
AF:
AC:
2464
AN:
151848
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0175 AC: 16573AN: 948486Hom.: 297 Cov.: 13 AF XY: 0.0168 AC XY: 8116AN XY: 481852
GnomAD4 exome
AF:
AC:
16573
AN:
948486
Hom.:
Cov.:
13
AF XY:
AC XY:
8116
AN XY:
481852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0162 AC: 2465AN: 151960Hom.: 38 Cov.: 32 AF XY: 0.0183 AC XY: 1358AN XY: 74308
GnomAD4 genome
AF:
AC:
2465
AN:
151960
Hom.:
Cov.:
32
AF XY:
AC XY:
1358
AN XY:
74308
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
57
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 26, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at